Description
Ipamorelin Research Overview
- What it does
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. It stimulates the release of growth hormone from the anterior pituitary without significantly increasing other hormones like cortisol, prolactin, or acetylcholine. Compared to GHRP-2 and GHRP-6, Ipamorelin is known for its cleaner action with minimal side effects and negligible appetite stimulation.
- What are the main reported benefits
- Increased natural growth hormone and IGF-1 secretion
- Improved muscle growth and fat metabolism
- Accelerated recovery from training and injury
- Enhanced sleep quality and REM sleep
- Improved skin texture and anti-aging benefits
- Minimal to no increase in appetite compared to other GHRPs
- Minimal to no impact on cortisol and prolactin levels
- What are its normal applications
- Research into growth hormone deficiency treatment
- Studies on muscle wasting conditions and sarcopenia
- Anti-aging and regenerative medicine research
- Athletic performance and recovery studies
- What are its common side effects
Ipamorelin is generally very well tolerated. Reported side effects may include:
- Mild headache
- Temporary dizziness
- Injection site irritation
- Mild water retention (rare)
Compared to other peptides, side effects are notably less frequent and less intense.
- What is the recommended administration or dosage
- Typical Dosage: 100 mcg to 300 mcg per injection
- Administration Route: Subcutaneous injection
Timing:
- 1 to 3 times per day (morning, post-workout, and/or before bedtime) to align with natural GH pulses
Preparation:
- Ipamorelin is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water before use.
Note: Often combined with CJC-1295 (without DAC) in research protocols for synergistic effects.
